Home > Press > Raymor Received a Strategic Order from STRYKER
Unique powder to be used to create lasting biocompatible coatings for its new generation of
innovative orthopedic implants
Raymor Received a Strategic Order from STRYKER Corporation for its Biomedical Titanium Powder
Montreal, Quebec, Canada | March 23, 2005
Raymor Industries is proud to announce that its wholly-owned industrial
subsidiary, AP&C Advanced Powders & Coatings Inc. (AP&C) has concluded a contract for Titanium
powder production with STRYKER Corporation (NYSE: SYK). STRYKER will use this unique powder,
given its sphericity and its purity, to create lasting biocompatible coatings for its new generation of
innovative orthopedic implants.
The ultra-spherical titanium powder allows STRYKER to produce high quality orthopedic implants.
Before issuing a purchase order to AP&C, Stryker conducted a worldwide search to find a powder
which would provide optimal longevity and biocompatibility for its orthopedic implants.
Thanks to AP&C’s patented plasma atomization process, biomedical powders are of a high purity, with
an exceptional sphericity. The spherical nature of the powder provides an evenly-distributed coating for
artificial joints, thus allowing for the optimization of the coating porosity, which facilitates tissue growth.
“The STRYKER contract represents for AP&C a breakthrough in the biomedical sector with a large US
company. STRYKER is one of the three global leaders in human orthopedic implants, and we are
pleased to have been selected by them,” said Mr. Stéphane Robert, President of Raymor Industries.
“STRYKER received FDA (US Food & Drug Administration) approval for these innovative orthopedic
implants using AP&C powder, enabling us to begin a long-term business relationship,” adds Mr. Robert.
According to Dr. Michel Drouet, Chief Scientist with AP&C, “At the beginning of the 90’s, I began
development work on this plasma atomization process, which is unique in the world, at Hydro-Québec’s
Shawinigan laboratories, in collaboration with Noranda. Thanks to AP&C, I am extremely happy to see
all this research effort leading to commercialization in the orthopedic implant sector with a client as
prestigious as STRYKER.”
“With this Titanium powder, other applications will be commercialized, including the metal injection
molding of components for the aerospace sector. With our Plasma Atomization Process, we can in fact
consider taking a foot-hold in other promising markets with other types of nano-sized and micron-sized
metallic powders,” adds Dr. Drouet.
With other negotiations underway, AP&C foresees the installation of a second reactor in its facility,
which could hold up to six units. The forecasted revenue from powder sales is in the order of $3.5
million per year, per reactor.
The world market for orthopedic implants was more than US$6.4 billion in 2002. Analysts from the
renowned Freedonia Group predict markets of US$8.7 billion in 2007 and US$11.6 billion in 2012. The
overall growth rate for this sector will be 6.2%. However, Freedonia Group and Frost & Sullivan both
agree that this growth rate can increase significantly (up to 15% per year), given the potential removal
of certain anti-inflammatory and pain medications from the market place by the FDA. As well, an aging
population will likely have an impact on the orthopedic implant market growth rate.
About Raymor Industries
Raymor Industries (TSX-V:RAR) has for mission to be the largest Canadian developer of
high technology and a producer/recycler of advanced materials and nanomaterials for high value-added
applications. In November 2004, Raymor Industries created a wholly-owned, industrial subsidiary,
AP&C Advanced Powders and Coatings, specializing in nanotechnology and advanced materials, and
comprising four operational divisions: (1) metal and ceramic coatings, which largely targets aerospace,
military, and mining applications; (2) spherical metallic powders, primarily used for biomedical and
aerospace applications; (3) nanotechnology products, including nano-powders, nano-coatings, and
carbon nanotubes for “the applications of tomorrow”; and (4) net-shape forming, a component
manufacturing technique used for ballistic protection and other aerospace and military applications.
Raymor holds the exclusive rights to 20 patents throughout the world.
For more information, visit www.raymor.com
Copyright © Raymor Industries
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
PEN Inc. Announces New Trading Symbol: PENC: Stock Continues Trading on the OTCQB September 3rd, 2014
Aspen Aerogels, Inc. to Present at Barclays CEO Energy-Power Conference August 27th, 2014
Harris & Harris Group Letter to Shareholders on Website August 19th, 2014
Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 August 12th, 2014
Rice launches Center for Quantum Materials: RCQM will immerse global visitors in cross-disciplinary research September 30th, 2014
How things coil: Researchers discover that simulation technology designed for Hollywood can be used as a predictive tool for understanding fundamental engineering problems September 29th, 2014
Iranian Scientists Determine Grain Size, Minimize Time of Nanocomposite Synthesis September 29th, 2014
Nanoparticles Used to Improve Quality of Bone Cement September 29th, 2014
'Stealth' nanoparticles could improve cancer vaccines October 1st, 2014
Stressed Out: Research Sheds New Light on Why Rechargeable Batteries Fail October 1st, 2014
New Absorber Will Lead to Better Biosensor: Biosensors are more sensitive and able to detect smaller changes in the environment October 1st, 2014
Graphene chips are close to significant commercialization October 1st, 2014